This radiotracer is based on a TNF inhibitor, namely the certolizumab pegol (CZP); it is a PEGylated humanized Fab fragment anti-TNF approved for the treatment of different immune diseases such as rheumatoid arthritis and Crohn disease [36]. The gene discussed is TNF; the disease is Crohn disease.